Option chain shows key data for Fredonia Mining's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Fredonia Mining.

Fredonia Mining (OTC:FREDD) Stock, Option Chain

Fredonia Mining Inc is engaged in the exploration of precious metals in Argentina. Fredonia holds licenses over three areas in the Deseado including the flagship El Dorado Monserrat Project, EDM, as well as El Aguila, and Hornia. Fredonia has undertaken exploration drill programs on EDM and El Aguila with encouraging results. Hornia is an underexplored area but historic drilling indicates the realistic potential for further discoveries. El Aguila is interpreted as a failed caldera with gold mineralization encountered in the radial as well as ring structures.

FREDONIA MNG INC NEW by FREDONIA MNG INC.

Fredonia Mining Inc

Piper Sandler analyst Crispin Love maintains Virtus Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRTS#NYSE">VRTS</a>) with a Overweight and raises the price target from $264 to $274.

News

Price Target

Analyst Ratings

VRTS

Piper Sandler Maintains Overweight on Virtus Inv, Raises Price Target to $274

Trading Ideas

VCIG

VCI Global Shares Halted On Circuit Breaker To The Upside, Stock Now Up 269.3%

Greenway Greenhouse Cannabis Corporation (CSE:<a class="ticker" href="https://www.benzinga.com/stock/GWAY#CSE">GWAY</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/GWAYF#OTCQB">GWAYF</a>) reported on Wednesday its second-quarter interim financial statements for the three months ended Sept. 30, 2024.
The Canadian cultivator of high-quality greenhouse cannabis reported a 52% year-over-year increase in revenue to CA$1.8 million ($1.3 million). Moreover, for the first half of the fiscal year, Greenway&#8217;s net revenue increased by 78% compared to the same period in 2023.
CEO Jamie D&#8217;Alimonte highlighted the company&#8217;s revenue growth, product performance and ongoing commitment to quality cannabis production in a press release issued Wednesday.
&#8220;We have also seen our MillRite brand maintain itself as the #2 ranked pre-roll in its size category, while achieving the #2 Indica and Sativa pre-roll in the size category over the same time," D&#8217;Alimonte said. "Quarter over quarter, we have seen the total number of units sold increase by over 70%. Our plan to deliver high-quality, affordable products to Ontario users is working. I look forward to introducing additional SKUs in the New Year.&#8221; Despite reporting a net loss, the company emphasized its strong market position and ongoing improvements as drivers of long-term growth.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40604376/greenway-cannabis-co-doubles-q1-net-revenue-yoy-highest-adjusted-ebitda-results-to-date">Greenway Cannabis Co. Doubles Q1 Net Revenue YoY, Highest Adjusted EBITDA Results To Date</a>
<h3 class="wp-block-heading">Q2 Financial Highlights</h3>
<ul>
<li>Gross loss of CA$88,955, down from a gross profit of CA$80,972 in the prior year, reflecting increased production costs and pricing pressures.</li>
<li>Loss and comprehensive loss totaled roughly CA$1 million, up from CA$662,213 loss and comprehensive loss in the same quarter of last year.</li>
<li>Net cash provided by operating activities of CA$743,731 compared to cash used of CA$664,171 in the same quarter of the previous year.</li>
<li>Adjusted EBITDA came in negative at CA$253,010, compared to an adjusted EBITDA loss of CA$ $112,221 in the prior year's period.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/40047803/greenways-full-year-net-loss-widens-sees-rebound-in-q4-as-revenue-increases-9-yoy">Greenway&#8217;s Full-Year Net Loss Widens, Sees Rebound In Q4 As Revenue Increases 9% YoY</a></li>
</ul>

Cannabis

Earnings

CSE:GWAY

GWAYF

Greenway Greenhouse Cannabis Sees 52% YoY Growth In Q2 Revenue Amid Rising Losses And Cost Challenges

Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) shares are trading lower after the company reported worse-than-expected 2025 fiscal-year third-quarter sales results on Tuesday <a href="https://www.benzinga.com//node/42201885">after the bell</a>.
The Details: Dell stock dropped approximately 6.5% following its earnings report on Tuesday and continues to decline on Wednesday morning. The earnings report included sales of $24.37 billion, missing analyst estimates of $24.65 billion but representing a 10% year-over-year increase.
The company broke down its sales further, reporting $11.4 billion from its Infrastructure Solutions Group (ISG) and $12.1 billion from its Client Services Group (CSG). In addition, the company reported adjusted earnings per share of $2.15, beating analyst estimates of $2.05.
&#8220;We continued to build on our AI leadership and momentum, delivering combined ISG and CSG revenue of&nbsp;$23.5 billion, up&nbsp;13%&nbsp;year over year,&#8221; said&nbsp;Yvonne McGill, CFO of Dell. 
&#8220;Our continued focus on profitability resulted in EPS growth that outpaced revenue growth, and we again delivered strong cash performance.&#8221;
On a note, Goldman Sachs remained positive about Dell&#8217;s long-term outlook, citing strong AI server demand and opportunities from a delayed PC refresh cycle expected to materialize in 2025. Goldman highlighted strong AI orders of $3.6 billion, contributing to a $4.5 billion backlog in AI servers.
However, Goldman Sachs acknowledged some short-term challenges, including weaker demand for PCs and a delayed recovery in the PC refresh cycle. The firm also noted that while AI server demand remains strong, Blackwell server shipments could face headwinds from component availability, potentially impacting next quarter's results.
Related Link: <a href="https://www.benzinga.com/insights/options/24/11/42217772/a-closer-look-at-gamestops-options-market-dynamics">A Closer Look at GameStop&#8217;s Options Market Dynamics</a>
DELL Price Action: At the time of publication, Dell stock is trading 12.9% lower at $123.48, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Photo via Shutterstock

Movers

DELL

What's Going On With Dell Shares Wednesday?

Piper Sandler analyst Harsh Kumar maintains Analog Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) with a Neutral and lowers the price target from $235 to $220.

Piper Sandler Maintains Neutral on Analog Devices, Lowers Price Target to $220

Flora Growth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGC#NASDAQ">FLGC</a>) confirmed Tuesday it renewed its sales orders for the Czech Republic and Slovakia through Just Brands UK&#8217;s customer Mirfa s.r.o.
Flora's four-year partnership with Mirfa is valued at a total demand of approximately $500,000 annually. The Florida-based cannabis operator has been supplying Mirfa with JustCBD branded products, including gummies, tinctures and oils.
&#8220;Our long-standing relationships in Europe are a testament to the strength of collaboration and mutual trust," said Clifford Starke, chairman and chief executive officer. "Over the past four years, this partnership has been a part of our European strategy, allowing us to bring premium products to customers in the Czech Republic and Slovakia. We are proud of the value this relationship continues to deliver, both in terms of revenue and brand recognition.&#8221;
The collaboration has established Flora as a supplier in the Czech and Slovakian markets, utilizing its product innovation and compliance expertise alongside Just Brands UK&#8217;s distribution network to deliver products to consumers.
The Czech Republic and Slovakia are among Europe&#8217;s emerging cannabis markets, with increasing consumer acceptance and regulatory progress driving growth opportunities for innovative companies. According to Statista, the Czech CBD market reached $34 million in 2024.
Mirfa is a Czech company specializing in CBD-infused products designed to enhance the well-being of both humans and pets. Its offerings include CBD gummies aimed at improving sleep, reducing stress and alleviating pain, as well as CBD treats formulated to promote calmness and comfort in dogs.
Read Also: <a href="https://www.benzinga.com/news/earnings/24/11/42009295/flora-growth-quarterly-revenue-falls-28-yoy-encouraged-by-president-elect-trump-and-the-potential-of-cannabis-reform">Flora Growth Quarterly Revenue Falls 28% YoY As Expenses Rise</a>
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h2 class="wp-block-heading">Flora Growth And International Markets</h2>
Renewed sales orders with Mirfa come on the heels of the company's <a href="https://www.benzinga.com/markets/cannabis/24/11/41720393/flora-growth-inks-medical-marijuana-supply-agreement-with-curaleaf">medical marijuana supply agreement</a> with Curaleaf Holdings (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>)&#8217;s subsidiary Northern Green Canada, Inc. Under the agreement, Northern Green will supply Flora with medicinal cannabis products that Flora will distribute in the German market.
In October, Flora also signed a <a href="https://www.benzinga.com/markets/cannabis/24/10/41332773/flora-growth-teams-up-with-cannabis-giant-canopy-to-enter-94m-australian-medical-marijuana-marke">distribution agreement</a> with Canopy Growth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) for the distribution of Canopy's Storz &amp; Bickel medical line of vaporizers in Australia. Flora&#8217;s subsidiary Australian Vaporizers will be in charge of distribution.
<h2 class="wp-block-heading">Price Action</h2>
Flora Growth shares closed Tuesday market session 2.65% higher at $1.55 per share.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42204210/why-youtubes-high-science-is-a-must-watch-for-cannabis-enthusiasts">YouTube&#8217;s High Science Is A Must-Watch For Cannabis Enthusiasts</a></li>
</ul>
Photo: Courtesy of Michele Ursi via Shutterstock

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

FLGC

Flora Growth Taps Europe's CBD Boom With $500K Czech-Slovak Partnership Renewal

Dr. Robert Murphy, the chief economist at Infineo, shared his thoughts on the evolution of blockchain in life insurance and the broader financial landscape during the <a href="https://www.benzinga.com/fintech-awards">Benzinga Fintech Awards,</a> where his company was recognized as Best Insurtech Company. 
Dr. Murphy highlighted Infineo's efforts to digitize the life insurance industry and how blockchain technology could reshape it by addressing traditional inefficiencies and enabling greater transparency.
<h4 class="wp-block-heading">Blockchain's Role in Life Insurance</h4>
At the conference, Dr. Murphy outlined Infineo&#8217;s groundbreaking work, which allows policyholders to tokenize the cash value of their life insurance policies on the blockchain.
See Also: <a href="https://www.benzinga.com/24/11/42218282/institutions-are-ready-to-play-how-blockchain-is-gaining-traction-in-traditional-finance">&#8216;Institutions Are Ready To Play&#8217;: How Blockchain Is Gaining Traction In Traditional Finance</a>
"What we're doing is allowing people to put the cash value of their life insurance policies on the blockchain, and they can mint stablecoins against it," he explained. This approach unlocks liquidity for policyholders while making life insurance a more accessible asset class for investors through fractionalized tokens.
Dr. Murphy also emphasized blockchain&#8217;s ability to address a longstanding issue in finance—opacity. "The financial sector right now is very opaque. Investors don't know what they're getting," he said. He compared the 2008 financial crisis, adding, "The mortgage-backed securities blowing up&#8230;part of the problem was nobody knew what was in these things. Now, with blockchain smart contracts, everybody knows exactly what they're buying."
<h4 class="wp-block-heading">Optimism for Regulatory Certainty</h4>
Another focal point of the discussion was the industry&#8217;s anticipation of regulatory clarity following the recent election. "Everybody, I think, is relieved to know that there's just going to be regulatory certainty," Dr. Murphy said. 
He noted that companies are not seeking special treatment but simply want a clear rulebook to continue building and innovating. "The best people will win, and the best companies will rise to the top," he added, underscoring the industry&#8217;s focus on competition and advancement.
<h4 class="wp-block-heading">The Future of Digital Assets and Blockchain</h4>
Looking ahead, Dr. Murphy predicted the continued integration of real-world assets onto the blockchain. "More and more real-world assets will be put on the blockchain," he stated. As transparency increases and familiarity with digital assets grows, he anticipates blockchain will become a standard feature of financial transactions rather than an emerging innovation.
Infineo's recognition at the Benzinga Fintech Awards highlights its leadership in modernizing the life insurance industry through blockchain. By combining regulatory clarity with cutting-edge technology, the company is driving an era of increased transparency and accessibility in financial markets.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42216782/long-term-bitcoin-holders-lock-in-202-billion-in-daily-realized-profits-setting-a-new-record">Long-Term Bitcoin Holders Locking In $2.02 Billion In Daily Realized Profits, Setting A New Record</a></li>
</ul>
Mohamed Hassan from Pixabay

Fintech news covering the emerging Financial Technology services sector

Fintech

Events

Exclusives

Interview

$3 Trillion Opportunity: Infineo Chief Economist Discusses Blockchain And The Future Of Life Insurance

Piper Sandler analyst Kashy Harrison maintains Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) with a Neutral and raises the price target from $18 to $20.

FLNC

Piper Sandler Maintains Neutral on Fluence Energy, Raises Price Target to $20

<a href="https://www.fda.gov/media/161640/download">https://www.fda.gov/media/161640/download</a>
&nbsp;
WARNING: HEMATOLOGIC MALIGNANCY Hematologic malignancy, including life-threatening cases of myelodysplastic syndrome, has occurred in patients treated with SKYSONA. Patients have been diagnosed between 14 months and 7.5 years after SKYSONA administration, and the cancers appear to be the result of the SKYSONA lentiviral vector, Lenti-D, integration in proto-oncogenes. Monitor patients closely for evidence of malignancy through complete blood counts at least every 6 months and through assessments for evidence for clonal expansion or predominance at least twice in the first year and annually thereafter; consider bone marrow evaluations as clinically indicated [see Warnings and Precautions (5.1)].

Biotech

General

BLUE

FDA Investigating Serious Risk Of Hematologic Malignancy Following Skysona (Elivaldogene Autotemcel)

Piper Sandler analyst Edward Tenthoff maintains Arrowhead Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARWR#NASDAQ">ARWR</a>) with a Overweight and lowers the price target from $62 to $45.

ARWR

Piper Sandler Maintains Overweight on Arrowhead Pharma, Lowers Price Target to $45

Floki has rallied 73% in the past mont, with market observers anticipating the uptrend to continue off the back of improving sentiment and <a href="https://www.benzinga.com/money/floki-price-prediction">bullish technical indicators</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Floki (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">FLOKI</a>)</td>
<td>&nbsp;$0.0002272</td>
<td>$2.2 Billion</td>
<td>&nbsp;+7.8%</td>
<td>&nbsp;-5.1%</td>
</tr>
<tr>
<td>Bonk (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONK</a>)</td>
<td>&nbsp;$0.00004434&nbsp;&nbsp;</td>
<td>$3.3 Billion</td>
<td>&nbsp;+6.2%</td>
<td>&nbsp;-17.4%</td>
</tr>
<tr>
<td>Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>)</td>
<td>&nbsp;$3.14</td>
<td>$3.14 Billion</td>
<td>&nbsp;+5.5%</td>
<td>&nbsp;-2.9%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Master Kenobi noted in a <a href="https://x.com/btc_MasterPlan/status/1861546426875916659">post</a> on X on Wednesday that Floki's rally was delayed by three weeks, originally expected by Oct. 21. 
He attributes this delay to broader market reactions following the U.S. elections.
He anticipates a continuation of the uptrend, which could result in a significant &#8220;pump&#8221; around Feb. 10 in a conservative scenario. 
In a more optimistic scenario, this could also happen in mid-December, thanks to the following catalysts:
<ol start="1">
<li>Bitcoin Dominance: Expected to persist for two more weeks before easing, creating opportunities for altcoins like Floki.</li>
<li>Market Signals: Positive movements in assets like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Binance Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>) point to a potential pump by late 2025.</li>
</ol>
Influencer InvestingHaven suggests that Floki has bounced from its dip, signaling a bullish breakout. 
However, he warns that the next major hurdle is surpassing its previous all-time high.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24FLOKI&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$FLOKI</a>&#39;s consolidation phase triggered a bullish reversal, reaching our 2024 target after bouncing from the &quot;Buy the Dip&quot; level. The next major challenge for <a href="https://twitter.com/hashtag/FLOKI?src=hash&amp;ref_src=twsrc%5Etfw">#FLOKI</a> lies in testing its all-time high (ATH). <a href="https://t.co/HeyNucZVd8">pic.twitter.com/HeyNucZVd8</a>
&mdash; InvestingHaven (@InvestingHaven) <a href="https://twitter.com/InvestingHaven/status/1861373838648582544?ref_src=twsrc%5Etfw">November 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Community News: Coinbase Assets <a href="https://x.com/CoinbaseAssets/status/1861145726618661333">announced</a> Floki becoming available for trading for residents in Germany. Users can now buy, sell, convert, send, receive, or store Floki through Coinbase, broadening the coin's accessibility.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/42102769/floki-beats-dogecoin-shiba-inu-with-double-digit-gains-after-coinbase-listing-announcement">Floki Beats Dogecoin, Shiba Inu With Double-Digit Gains After Coinbase Listing Announcement</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BNB

$BONK

$DOGE

$FLOKI

$WIF

Floki Skyrockets 73% Over The Past Month: What Is Going On?

Piper Sandler analyst Frank Schiraldi maintains M&amp;T Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) with a Overweight and raises the price target from $205 to $243.

Piper Sandler Maintains Overweight on M&T Bank, Raises Price Target to $243

Jackson Finl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JXN#NYSE">JXN</a>) short percent of float has risen 20.62% since its last report. The company recently reported that it has 3.64 million shares sold short, which is 5.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.22 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Jackson Finl Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732725026_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Jackson Finl has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Jackson Finl's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Jackson Finl's peer group average for short interest as a percentage of float is 1.63%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Jackson Finl's Recent Short Interest

Blackstone's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) short percent of float has fallen 13.7% since its last report. The company recently reported that it has 17.00 million shares sold short, which is 2.33% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.36 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Blackstone Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732725021_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Blackstone has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Blackstone's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Blackstone's peer group average for short interest as a percentage of float is 3.30%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(BX) - Analyzing Blackstone's Short Interest

Ryder System's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) short percent of float has risen 27.23% since its last report. The company recently reported that it has 910 thousand shares sold short, which is 2.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.19 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Ryder System Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732725016_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ryder System has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ryder System's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ryder System's peer group average for short interest as a percentage of float is 4.98%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Ryder System's Recent Short Interest

Piper Sandler analyst Clarke Jeffries maintains Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) with a Neutral and raises the price target from $257 to $311.

ADSK

Piper Sandler Maintains Neutral on Autodesk, Raises Price Target to $311

Piper Sandler analyst James Fish maintains Nutanix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) with a Overweight and raises the price target from $77 to $83.

NTNX

Piper Sandler Maintains Overweight on Nutanix, Raises Price Target to $83

Piper Sandler analyst Biren Amin maintains Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Overweight and lowers the price target from $200 to $182.

SRPT

Piper Sandler Maintains Overweight on Sarepta Therapeutics, Lowers Price Target to $182

Piper Sandler analyst Rob Owens maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Overweight and raises the price target from $290 to $375.

CRWD

Piper Sandler Maintains Overweight on CrowdStrike Holdings, Raises Price Target to $375

Vertically integrated cannabis company C21 Investments Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/CXXI#CSE">CXXI</a>) (OTCQX: CXXIF) announced on Tuesday its plan to repurchase approximately 5% of its issued and outstanding common shares as part of a share buyback program, with the intention of canceling the repurchased shares to enhance shareholder value.
<h3 class="wp-block-heading">What Happened</h3>
Under the normal course issuer bid (NCIB), C21 may repurchase up to 6,002,390 of its common shares, representing 5% of its total issued and outstanding shares.
The program will run for a year, starting Monday, Dec. 2, 2024, providing the company with the flexibility to make purchases when market conditions are favorable. Purchases will depend on market conditions, and C21 retains the right to suspend or discontinue the program at any time.
The company has appointed Haywood Securities Inc. as its broker to conduct the NCIB transactions on its behalf.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40418941/inflationary-pressures-continue-to-impact-cannabis-industry-says-c21-as-it-reports-net-loss-and-">&#8216;Inflationary Pressures Continue To Impact Cannabis Industry, Says C21 As It Reports Net Loss And Decline In Nevada Sales</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Why It Matters</h3>
C21 said in a press release it opted for the move as it "believes that the market price of the common shares may not fully reflect the value of its business and prospects," adding that "purchasing its own common shares for cancellation is an appropriate strategy for increasing long-term shareholder value and represents an appropriate use of the company&#8217;s financial resources."
According to the company's Nov. 14 earnings report, &nbsp;its second-quarter revenue totaled $7.5 million, representing a 14% increase <a href="https://www.benzinga.com/news/earnings/24/11/42015411/c21-reports-q2-revenue-up-14-qoq-south-reno-cannabis-dispensary-sees-53-sales-growth">from the first quarter.</a>
The company highlighted strong sales growth in its South Reno dispensary, with a 53% increase during the second quarter, reaching $416,000 in September. Sales continued to grow in October, rising another 14% to $475,000. These results underscore the company&#8217;s ability to fund the share buyback program while continuing to expand its operations.
CEO and president Sonny Newman said quarterly results &#8220;have exceeded our expectations and we continue to see robust sales growth into the new quarter."
The company&#8217;s shares traded 4.34% higher at 23 cents per share at the time of writing on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41338043/the-biggest-little-company-in-cannabis-c21-investments-dominates-reno-nv">The Biggest Little Company In Cannabis: C21 Investments Dominates Reno, NV</a></li>
</ul>

Comments

Fredonia Mining

Fredonia Mining (FREDD) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga